Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: P2C 9165 Principal Investigator: Adkins, Douglas
Title: NCI 9165 / UC 12-1359: A randomized phase II trial of ARQ 197 (tivantinib)/cetuximab versus cetuximab in patients with recurrent/metastatic head and neck cancer
Phase: II Disease Site: Lip, Oral Cavity and Pharynx
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test how well cetuximab alone or in combination with ARQ197 (tivantinib) are able to treat head and neck squamous cell carcinomas that have recurred or are metastatic.
 
More Information:
ClinicalTrials.gov Site
Internal Protocol Documents (requires Siteman administrative database password)